CA
BLFS icon

Clearstead Advisors’s BioLife Solutions BLFS Stock Holding History

Clearstead Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-475
Closed -$10.2K – 3111
2025
Q2 		$10.2K Hold
475
– – ﹤0.01% 1885
2025
Q1 		$10.8K Hold
475
– – ﹤0.01% 1591
2024
Q4 		$12.3K Hold
475
– – ﹤0.01% 1522
2024
Q3 		$11.9K Buy
+475
New +$11.2K ﹤0.01% 1552

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Clearstead Advisors's BLFS Position: Q3 2025 in Review

Clearstead Advisors sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 475 shares — an estimated $10.2K sold.

Clearstead Advisors first reported a position in BLFS in Q3 2024 and held it in 4 quarters. The position peaked at $12.3K in Q4 2024. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Clearstead Advisors reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • Clearstead Advisors sold 475 BioLife Solutions shares in Q3 2025, an estimated $10.2K.
  • Clearstead Advisors first reported a position in BioLife Solutions in Q3 2024 and held it in 4 quarters.
  • Clearstead Advisors's BioLife Solutions position peaked at $12.3K in Q4 2024.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Clearstead Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.